APA |
Koç, Z. P., Özcan, P. P., Oruçoğlu, N., Sayar, H. (2022). Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging, 2(2), 1-5. |
|
AMA |
Koç ZP, Özcan PP, Oruçoğlu N, Sayar H. Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. Ağustos 2022;2(2):1-5. |
|
Chicago |
Koç, Zehra Pınar, Pınar Pelin Özcan, Nurdan Oruçoğlu, ve Hamide Sayar. “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging 2, sy. 2 (Ağustos 2022): 1-5. |
|
EndNote |
Koç ZP, Özcan PP, Oruçoğlu N, Sayar H (01 Ağustos 2022) Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging 2 2 1–5. |
|
IEEE |
Z. P. Koç, P. P. Özcan, N. Oruçoğlu, ve H. Sayar, “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”, Molecular Oncologic Imaging, c. 2, sy. 2, ss. 1–5, 2022. |
|
ISNAD |
Koç, Zehra Pınar vd. “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging 2/2 (Ağustos 2022), 1-5. |
|
JAMA |
Koç ZP, Özcan PP, Oruçoğlu N, Sayar H. Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2022;2:1–5. |
|
MLA |
Koç, Zehra Pınar vd. “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging, c. 2, sy. 2, 2022, ss. 1-5. |
|
Vancouver |
Koç ZP, Özcan PP, Oruçoğlu N, Sayar H. Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2022;2(2):1-5. |
|